CagriSema (Cagrilintide + Semaglutide)
Description:
CagriSema is a research peptide combination consisting of Cagrilintide and Semaglutide. It is designed to study appetite regulation, weight management, and metabolic function by combining the effects of an amylin analogue with a GLP-1 receptor agonist.
Compliance Notice:
For research use only. Not intended for human or veterinary use, medical treatment, or diagnostic applications. Users must comply with all applicable laws and regul
Research Applications:
- Obesity and weight management research
- Appetite regulation and satiety studies
- Metabolic and endocrine system research
Storage and Handling:
- Store lyophilized powder at -20°Cin a dry, dark place
- After reconstitution, store at 2–8°C
- Avoid repeated freeze–thaw cycles
Product Specifications:
Purity: ≥99% (HPLC Certified)
Appearance: Lyophilized White Powder
Solubility: Soluble In Suitable Laboratory Agents
Compliance Notice:
For research use only. Not intended for human or veterinary use, medical treatment, or diagnostic purposes. Users are responsible for complying with all applicable laws and regulations.
| Size |
5mg ,10mg ,20mg |
|---|

Reviews
There are no reviews yet.